Background Off-label prescription of inhaled bronchodilators (IB) is frequent, despite the fact
that they can be ineffective and increase avoidable healthcare costs. Objective To analyse …

[Use of inhaled bronchodilators by primary care patients]. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

Objective: Inaccurate and incomplete prescribing of nebulized bronchodilators can result in
uncertainty and suboptimal treatment. A prospective study was carried out to assess the …

Background Although the efficacy of inhaled long-acting bronchodilators has been well
documented in randomised controlled studies, whether similar effects are obtained in real …

Abstract Background and objective Bronchodilators (BDs) are the cornerstone of COPD
treatment. However, their underuse has been reported in real-life studies. PUMA is a primary …

Introduction: Inhaled bronchodilators are the mainstay of the current management of COPD
at all stages of the disease, and are critical in the symptomatic management of asthma …

Bronchodilators are still key elements in the treatment of both COPD and asthma and are
likely to remain so for years to come.

Background and objective While several studies have found that prescribing practices do
not conform to chronic obstructive pulmonary disease (COPD) treatment guidelines, none …

Rationale: Long-acting β-adrenergic agonists and long-acting anticholinergic agents are
recommended for the management of patients with stable chronic obstructive pulmonary …

The use of bronchodilators plays an important role in respiratory conditions such as asthma
and COPD. This article looks at the types of bronchodilators available, their onset and …